SCHEMBL7445345

SCHEMBL7445345

O=Cc1ccc(Cl)c(C(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
TP53 P04637 1/20 0.59
POLB P06746 5/20 0.50
RAB9A P51151 5/20 0.50
TDP1 Q9NUW8 4/20 0.50
NPC1 O15118 4/20 0.50
KDM4E B2RXH2 4/20 0.50
MAPT P10636 3/20 0.50
LMNA P02545 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
NSD2 O96028 1/20 0.48
PKM P14618 1/20 0.48
APEX1 P27695 1/20 0.48
CASP3 P42574 1/20 0.48
RECQL P46063 1/20 0.48
CASP6 P55212 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
CTSB P07858 1/20 0.46
VCAM1 P19320 1/20 0.46
GAA P10253 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555818 0.85 GRIK1 (0.53) ALDH1A1TP53POLBRAB9ATDP1
SCHEMBL19694977 0.84 SMN1; SMN2 (0.59) ALDH1A1TP53RAB9ANPC1KDM4E
SCHEMBL5112998 0.82 ALDH1A1 (0.57) ALDH1A1TP53POLBRAB9ATDP1
SCHEMBL20491041 0.82 ALDH1A1 (0.55) ALDH1A1TP53POLBRAB9ATDP1
SCHEMBL10041228 0.82 ALDH1A1 (0.57) ALDH1A1TP53POLBRAB9ATDP1
SCHEMBL31312290 0.81 TRIM24 (0.62) ALDH1A1TP53POLBRAB9ANPC1
SCHEMBL2560594 0.81 TRIM24 (0.62) ALDH1A1TP53POLBRAB9ANPC1
SCHEMBL4613992 0.81 ALDH1A1 (0.52) ALDH1A1POLBRAB9ATDP1NPC1
SCHEMBL30589393 0.81 ALDH1A1 (0.52) ALDH1A1POLBRAB9ATDP1NPC1
SCHEMBL7494926 0.79 KDM4E (0.54) ALDH1A1TP53POLBRAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
CN-104513213-A Fxr agonist KBP BIOSCIENCES CO LTD 2015-04-15 CN disclosed
EP-2828253-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME Abide Therapeutics, Inc. (US) 2015-01-28 EP disclosed
WO-2013142307-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME ABIDE THERAPEUTICS (US) 2013-09-26 WO disclosed
WO-2010011584-A2 PROCESS FOR MAKING A RENIN INHIBITOR MERCK & CO., INC. (US) 2010-01-28 WO disclosed
EP-0912567-B1 CARBOLINE DERIVATIVES ICOS CORP (US) 2002-04-10 EP disclosed
US-6306870-B1 PHOSPHODIESTERASE ENZYME INHIBITORS, CARDIOVASCULAR DISORDERS AND SEXUAL DISORDERS ICOS CORPORATION 2001-10-23 US disclosed
US-6117881-A POTENT AND SELECTIVE INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE SPECIFIC PHOSPHODIESTERASE ICOS CORPORATION (US) 2000-09-12 US disclosed
US-6043252-A A POTENT AND SELECTIVE INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE SPECIFIC PHOSPHODIESTERASE (CGMP-SPECIFIC PDE); TREATING CARDIOVASCULAR DISORDERS AND ERECTILE DYSFUNCTION ICOS CORPORATION (US) 2000-03-28 US disclosed
EP-0912567-A1 CARBOLINE DERIVATIVES ICOS CORPORATION (US) 1999-05-06 EP disclosed
WO-1997043287-A1 CARBOLINE DERIVATIVES ICOS CORPORATION (US) 1997-11-20 WO disclosed